Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome

Approximately 50% of patients undergoing cardioversion present with a recurrence of Atrial Fibrillation ( AF) within 3-6 months of cardioversion despite ongoing antiarrhythmic treatment (AAD). Inflammation has been involved in the pathogenesis of both metabolic syndrome (MS) and atrial fibrillation....

Full description

Saved in:
Bibliographic Details
Main Authors: Jani Ylber (Author), Neziri Entela (Author), Paparisto Sokol (Author), Bara Petrit (Author), Haxhirexha Kastriot (Author), Pocesta Bekim (Author), Rexhepi Atila (Author), Xhunga Sotiraq (Author), Serani Artur (Author), Ferati Fatmir (Author), Zeqiri Agim (Author), Kamberi Ahmet (Author)
Format: Book
Published: Sciendo, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9758bccaa38b4bf9b697fc7a0fcecb4c
042 |a dc 
100 1 0 |a Jani Ylber  |e author 
700 1 0 |a Neziri Entela  |e author 
700 1 0 |a Paparisto Sokol  |e author 
700 1 0 |a Bara Petrit  |e author 
700 1 0 |a Haxhirexha Kastriot  |e author 
700 1 0 |a Pocesta Bekim  |e author 
700 1 0 |a Rexhepi Atila  |e author 
700 1 0 |a Xhunga Sotiraq  |e author 
700 1 0 |a Serani Artur  |e author 
700 1 0 |a Ferati Fatmir  |e author 
700 1 0 |a Zeqiri Agim  |e author 
700 1 0 |a Kamberi Ahmet  |e author 
245 0 0 |a Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome 
260 |b Sciendo,   |c 2024-03-01T00:00:00Z. 
500 |a 2734-6382 
500 |a 10.2478/rjc-2024-0003 
520 |a Approximately 50% of patients undergoing cardioversion present with a recurrence of Atrial Fibrillation ( AF) within 3-6 months of cardioversion despite ongoing antiarrhythmic treatment (AAD). Inflammation has been involved in the pathogenesis of both metabolic syndrome (MS) and atrial fibrillation. Evidence has indicated that inflammatory changes is essential for recurrence of AF. Therefore, identifying patients at high risk of AF recurrence remains challenging. 
546 |a EN 
690 |a crp levels 
690 |a inflammation 
690 |a metabolic syndrome 
690 |a atrial fibrillation 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Romanian Journal of Cardiology, Vol 34, Iss 1, Pp 24-30 (2024) 
787 0 |n https://doi.org/10.2478/rjc-2024-0003 
787 0 |n https://doaj.org/toc/2734-6382 
856 4 1 |u https://doaj.org/article/9758bccaa38b4bf9b697fc7a0fcecb4c  |z Connect to this object online.